Sano Pharma Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 14-12-2024
- Paid Up Capital ₹ 4.56 Cr
as on 14-12-2024
- Company Age 26 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.00 Cr
as on 14-12-2024
- Revenue -22.41%
(FY 2020)
- Profit -22.79%
(FY 2020)
- Ebitda -69.57%
(FY 2020)
- Net Worth 6.62%
(FY 2020)
- Total Assets 6.06%
(FY 2020)
About Sano Pharma
The Corporate was formerly known as Sano Cast Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 4.56 Cr.
The company has closed loans amounting to ₹1.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Lanka Vittal, Lanka Padmasree, Nagasai Lanka, and One other member serve as directors at the Company.
- CIN/LLPIN
U24100TG1998PTC029002
- Company No.
029002
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Mar 1998
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- LocationPatancheru, Medak District., Telangana
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sano Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lanka Vittal  | Managing Director | 04-Mar-1998 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sai Lanka | Director | 15-Nov-2021 | Current |
| Lanka Padmasree | Director | 14-Mar-1998 | Current |
| Nagasai Lanka | Director | 15-Nov-2021 | Current |
Financial Performance of Sano Pharma.
Sano Pharma Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 22.41% decrease. The company also saw a substantial fall in profitability, with a 22.79% decrease in profit. The company's net worth moved up by a moderate rise of 6.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sano Pharma?
In 2019, Sano Pharma had a promoter holding of 77.72% and a public holding of 22.28%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sano High Grade Spectro Castings Private LimitedActive 19 years 10 monthsLanka Vittal, Lanka Padmasree and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Andhra Pradesh State Financial Corporation Creation Date: 29 Jan 2014 | ₹4.20 M | Satisfied |
Andhra Bank Creation Date: 30 Jun 1999 | ₹2.00 M | Satisfied |
A.P.S.F.C. Creation Date: 18 Nov 1998 | ₹3.80 M | Satisfied |
How Many Employees Work at Sano Pharma?
Unlock and access historical data on people associated with Sano Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sano Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sano Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
